In this study, we discovered an unreported VCP–TFE3 tRCC that had worse prognosis compared to other fusion Xp11.2 RCC. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.